Cargando…

Antithrombotic management of patients with atrial fibrillation—Dutch anticoagulant initiatives anno 2020

In recent years, as more and more experience has been gained with prescribing direct oral anticoagulants (DOACs), new research initiatives have emerged in the Netherlands to improve the safety and appropriateness of DOAC treatment for stroke prevention in patients with atrial fibrillation (AF). Thes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chu, G., Seelig, J., Trinks-Roerdink, E. M., Geersing, G. J., Rutten, F. H., de Groot, J. R., Huisman, M. V., Hemels, M. E. W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bohn Stafleu van Loghum 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418291/ https://www.ncbi.nlm.nih.gov/pubmed/32780327 http://dx.doi.org/10.1007/s12471-020-01446-6

Ejemplares similares

Anticoagulants in frail elderly patients with atrial fibrillation: a delicate balance
por: Trinks-Roerdink, Emmy M., et al.
Publicado: (2023)

External validation and updating of prediction models of bleeding risk in patients with cancer receiving anticoagulants
por: Trinks-Roerdink, EM, et al.
Publicado: (2023)

Design and rationale of DUTCH-AF: a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillation
por: Chu, Gordon, et al.
Publicado: (2020)

Benefit of integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trial
por: Trinks-Roerdink, E M, et al.
Publicado: (2023)

Determinants of label non-adherence to non-vitamin K oral anticoagulants in patients with newly diagnosed atrial fibrillation
por: Seelig, J, et al.
Publicado: (2022)

Atrial fibrillation: trends in prevalence and antithrombotic prescriptions in the community
por: Joosten, L. P. T., et al.
Publicado: (2022)

A systematic review and meta-analysis of diagnostic delay in pulmonary embolism
por: van Maanen, R., et al.
Publicado: (2022)

When to withhold oral anticoagulation in atrial fibrillation – an overview of frequent clinical discussion topics
por: Seelig, Jaap, et al.
Publicado: (2019)

Integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trial
por: Trinks-Roerdink, Emmy M., et al.
Publicado: (2023)

Changes in anticoagulant prescription in Dutch patients with recent-onset atrial fibrillation: observations from the GARFIELD-AF registry
por: Seelig, J., et al.
Publicado: (2020)

Optimal long-term antithrombotic management of atrial fibrillation: life cycle management
por: Pisters, R., et al.
Publicado: (2018)

Adherence to anticoagulation: an ongoing challenge
por: Seelig, J., et al.
Publicado: (2019)

Complex clinical scenarios with the use of direct oral anticoagulants in patients with atrial fibrillation: a multidisciplinary expert advisory board
por: Mulder, B. A., et al.
Publicado: (2020)

Antithrombotic treatment in atrial fibrillation patients needing percutaneous coronary intervention
por: Huisman, M. V.
Publicado: (2021)

New-onset atrial fibrillation during critical illness: another piece of the puzzle
por: Seelig, Jaap, et al.
Publicado: (2022)

Impact of different anticoagulation management strategies on outcomes in atrial fibrillation: Dutch and Belgian results from the GARFIELD‐AF registry
por: Seelig, Jaap, et al.
Publicado: (2020)

Clinical consequences of off-label reduced dosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis
por: Joosten, Linda P T, et al.
Publicado: (2023)

Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial
por: Joosten, Linda P T, et al.
Publicado: (2019)

Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort
por: Huisman, Menno V., et al.
Publicado: (2016)

Prevalence and Predictors of Nonadherence to Direct Oral Anticoagulant Treatment in Patients with Atrial Fibrillation
por: van der Horst, Sabine F. B., et al.
Publicado: (2023)

Opportunistic screening for atrial fibrillation using a photoplethysmography technique in geriatric patients, a preliminary analysis of the Dutch-GERAF Study
por: Zwart, L A R, et al.
Publicado: (2023)

Prorenin anno 2008
por: Danser, A. H. Jan, et al.
Publicado: (2008)

Integrated management of atrial fibrillation including tailoring of anticoagulation in primary care: study design of the ALL-IN cluster randomised trial
por: van den Dries, Carline J, et al.
Publicado: (2017)

The AnnoLite and AnnoLyze programs for comparative annotation of protein structures
por: Marti-Renom, Marc A, et al.
Publicado: (2007)

Chimica-fisica: primo anno
por: Passatore, G, et al.
Publicado: (1950)

Rheumatic heart disease anno 2020: Impacts of gender and migration on epidemiology and management
por: Mutagaywa, Reuben K., et al.
Publicado: (2020)

Anno Domini MCMXXI /
por: Akhmatova, Anna Andreevna, 1889-1966
Publicado: (1978)

Il trentesimo anno
por: Bachmann, Ingeborg, 1926-1973

L'anno nudo /
por: Pilniak, Boris, 1894-1937
Publicado: (1976)

Antithrombotic therapy in patients undergoing TAVI: an overview of Dutch hospitals
por: Nijenhuis, V. J., et al.
Publicado: (2013)

Anno Domini : y otras parábolas
por: Steiner, George, 1929-2020
Publicado: (2014)

Atrial fibrillation and comorbidities: Clinical characteristics and antithrombotic treatment in GLORIA-AF
por: Kozieł, Monika, et al.
Publicado: (2021)

Het vaccin anno 1796
por: Heynick, Frank
Publicado: (2021)

Update on Antithrombotic Therapy for Stroke Prevention in Atrial Fibrillation
por: Abcede, Hermelinda G., et al.
Publicado: (2010)

The Number of Concomitant Drugs and the Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation
por: van den Dries, Carline J., et al.
Publicado: (2020)

The effect of hospital-based antithrombotic stewardship on adherence to anticoagulant guidelines
por: Dreijer, Albert R., et al.
Publicado: (2019)

La frontera (Anno Domini 363) /
por: Arce, Javier
Publicado: (1995)

Safety of off‐label dose reduction of non‐vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
por: van den Dries, Carline J., et al.
Publicado: (2022)

Efficacy and Safety of Antithrombotic Therapy With Oral Anticoagulants in Real-World Elderly Patients With Acute Coronary Syndrome and Atrial Fibrillation
por: Wu, Yangxun, et al.
Publicado: (2022)

Optimal Antithrombotic Treatment of Patients with Atrial Fibrillation Early after an Acute Coronary Syndrome—Triple Therapy, Dual Antithrombotic Therapy with an Anticoagulant… Or, Rather, Temporary Dual Antiplatelet Therapy?
por: Limbruno, Ugo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0aj00m2fi4gqctub5ckccg8u7m